New leakproof vials offer enhanced sample and user safety
Thermo's Samco Clicktainer vials provide secure and reliable sample collection and transport.
A new series of leakproof vials has been developed to provide sample protection and user safety by enabling correct cap application every time. The unique lid-lock design of the Thermo Scientific Samco Clicktainer vials makes them ideal for the secure transport of valuable and often hazardous clinical, research and forensic samples.
The new Samco Clicktainer vials are designed for the secure collection and handling of fluid, solid and powder samples, including urine, sputum and stool specimens. They bear the CE mark and are compliant with applicable FDA regulations. They also are 95kPa leak and pressure tested in accordance with standards BS EN 14401 and 14254, respectively, and are tested to support their use in hospital pneumatic transport systems.
"Enabling the safe and secure collection and transportation of specimen samples is essential for the efficient operation of many laboratory types where leakages can not only lead to inconveniences associated with lost work, but can also be hazardous for laboratory personnel," said Eric Roman, president, laboratory products, Thermo Fisher Scientific. "Our new Samco Clicktainer vials are rigorously tested to ensure they are leakproof, and our click seal system provides users with peace of mind that their specimens are secure following collection."
Available in 120 mL and 90 mL formats with an optional built-in temperature strip, users simply turn the lid gently past the lock symbol and an audible 'click' sound will signify the lid is fully sealed. The click mechanism is also tactile, and clear markers on the lid and vial also indicate when the lid is correctly closed. As such, users can be confident their samples are safe, while the durable tab design reduces the risk of torn gloves or break-off leading to potential contamination of the sample.
The wide 53-mm opening is designed for easy specimen collection and handling, and the cap is available in multiple colors for sample differentiation and management. In addition, the vials are available gamma irradiated to a sterility assurance level (SAL) of 10-6 for routine microbiology and more sensitive applications or non-sterile for general use.
The Clicktainer vials are compliant with the requirements of In Vitro Diagnostic Device Directive 98/79/EC.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.